We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
(+10%)
Cap. Flow
+$812M
Cap. Flow
% of AUM
7.54%
Top 10 Holdings %
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$32.7M |
| 2 |
Eli Lilly
LLY
|
+$31M |
| 3 |
La-Z-Boy
LZB
|
+$17.4M |
| 4 |
Ubiquiti
UI
|
+$17.1M |
| 5 |
TriMas Corp
TRS
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LSB Industries
LXU
|
+$14M |
| 2 |
K
Kellanova
K
|
+$13.7M |
| 3 |
Apple
AAPL
|
+$13.1M |
| 4 |
Prosperity Bancshares
PB
|
+$11.7M |
| 5 |
Fluor
FLR
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.72% |
| 2 | Industrials | 12.7% |
| 3 | Healthcare | 12.22% |
| 4 | Financials | 10.93% |
| 5 | Energy | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCR
201
DELISTED
CR Bard Inc.
BCR
| $15.1M | 0.14% |
102,281
-17,166
| -14% | -$2.38M |
|
202
United Therapeutics
UTHR
$26.3B
| $15.1M | 0.14% |
160,974
+21,425
| +15% | +$2.19M |
|
|
203
TriMas Corp
TRS
$1.43B
| $15.1M | 0.14% |
+571,607
| New | +$16.1M |
|
204
Amdocs
DOX
$5.53B
| $15M | 0.14% |
323,185
+100,721
| +45% | +$4.4M |
|
205
Robert Half
RHI
$3.61B
| $15M | 0.14% |
357,777
+9,070
| +3% | +$373K |
|
|
THOR
206
DELISTED
THORATEC CORPORATION
THOR
| $15M | 0.14% |
417,819
+50,910
| +14% | +$1.82M |
|
|
TAL
207
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
| $14.9M | 0.14% |
347,284
+57,350
| +20% | +$2.55M |
|
|
AUXL
208
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $14.9M | 0.14% |
546,707
-33,035
| -6% | -$877K |
|
|
IGTE
209
DELISTED
IGATE CORPORATION
IGTE
| $14.9M | 0.14% |
470,991
+143,713
| +44% | +$4.95M |
|
210
Travelers Companies
TRV
$80.8B
| $14.8M | 0.14% |
174,313
-1,747
| -1% | -$147K |
|
|
MCRS
211
DELISTED
MICROS SYSTEMS INC
MCRS
| $14.7M | 0.14% |
278,398
+107,094
| +63% | +$5.94M |
|
212
Unisys
UIS
$227M
| $14.7M | 0.14% |
483,177
-1,617
| -0.3% | -$52.1K |
|
|
SNDK
213
DELISTED
SANDISK CORP
SNDK
| $14.5M | 0.14% |
179,197
+80
| +0% | +$5.9K |
|
214
Sinclair Inc
SBGI
$974M
| $14.3M | 0.13% |
528,932
+91,911
| +21% | +$2.73M |
|
|
MEAS
215
DELISTED
MEASUREMENT SPECIALTIES INC
MEAS
| $14.3M | 0.13% |
210,738
+35,029
| +20% | +$2.11M |
|
216
Hope Bancorp
HOPE
$1.72B
| $14.2M | 0.13% |
830,898
+134,806
| +19% | +$2.22M |
|
217
Broadcom
AVGO
$1.82T
| $14.2M | 0.13% |
2,203,340
-816,640
| -27% | -$4.79M |
|
|
AHT
218
Ashford Hospitality Trust
AHT
$21M
| $14.2M | 0.13% |
1,347
+431
| +47% | +$3.97M |
|
219
Principal Financial Group
PFG
$23.6B
| $14.1M | 0.13% |
307,137
-29,222
| -9% | -$1.34M |
|
|
WIBC
220
DELISTED
WILSHIRE BANCORP INC
WIBC
| $14.1M | 0.13% |
1,270,766
+210,116
| +20% | +$2.21M |
|
|
EMC
221
DELISTED
EMC CORPORATION
EMC
| $14.1M | 0.13% |
513,117
-146,182
| -22% | -$3.8M |
|
222
Lithia Motors
LAD
$7.78B
| $14M | 0.13% |
210,990
+37,125
| +21% | +$2.32M |
|
|
PDCO
223
DELISTED
Patterson Companies, Inc.
PDCO
| $14M | 0.13% |
334,768
+91,665
| +38% | +$3.74M |
|
|
PCP
224
DELISTED
PRECISION CASTPARTS CORP
PCP
| $13.9M | 0.13% |
55,058
-1,252
| -2% | -$324K |
|
|
RAI
225
DELISTED
Reynolds American Inc
RAI
| $13.9M | 0.13% |
518,778
-129,952
| -20% | -$3.27M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2014 Portfolio in Review
As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.
- Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
- Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
- Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
- Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
- Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
- Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
- Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.
Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.